4 documents found, page 1 of 1
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV co...
Bhering, M; Duarte, R; Kritski, ABACKGROUND: Brazil ranks 14th worldwide in the number of TB cases and 19th in terms of TB-HIV co-infected cases. This study aims at identifying clinical and demographic factors associated with unsuccessful treatment outcomes (loss to follow-up, treatment failure and death) of HIV-positive patients with multidrug-resistant TB (MDR-TB) in Rio de Janeiro State, Brazil. METHODS: This was a retrospective cohort stud...
Multidrug-Resistant Tuberculosis in Portugal: Patients' Perception of the Chall...
Bhering, M; Sarubbi Junior, V; Kritski, A; Souza, FBA; Duarte, RIntroduction: The increase in drug-resistant tuberculosis (TB) threatens global progress in eliminating TB, and constitutes a major challenge for patients, health-care workers and health services. Treatment for multidrug-resistant TB (MDR-TB) can last almost 2 years, and is more expensive, more toxic, and less effective than treating TB caused by drug-sensitive bacilli. This study aims to analyze patients’ narr...
Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in ...
Bhering, M; Duarte, R; Kritski, ASetting The State of Rio de Janeiro stands out as having the second highest incidence and the highest mortality rate due to TB in Brazil. This study aims at identifying the factors associated with the unfavourable treatment of MDR/XDR-TB patients in that State. Method Data on 2269 MDR-TB cases reported in 2000–2016 in Rio de Janeiro State were collected from the Tuberculosis Surveillance System. Bivariate and m...
Eliminating tuberculosis in Latin America: making it the point
Duarte, R; Silva, DR; Rendon, A; Alves, TG; Rabahi, MF; Centis, R; Kritski, A; Migliori, GBn/a